SCHEMBL7657250

SCHEMBL7657250

COC(=O)C(c1ccccc1)N1CCCC1

nearest known ligand 0.94

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.94
ALDH1A1 P00352 3/20 0.94
KMT2A Q03164 2/20 0.94
MEN1 O00255 1/20 0.94
OPRM1 P35372 1/20 0.68
OPRK1 P41145 1/20 0.68
OPRL1 P41146 1/20 0.68
GAA P10253 1/20 0.63
CHRM2 P08172 1/20 0.59
CHRM1 P11229 1/20 0.59
CHRM3 P20309 1/20 0.59
TSHR P16473 1/20 0.55
NPY2R P49146 3/20 0.54
SMN1; SMN2 Q16637 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2789416 0.98 LMNA (0.97) LMNAALDH1A1KMT2AMEN1OPRM1
SCHEMBL1819794 0.98 LMNA (0.97) LMNAALDH1A1KMT2AMEN1OPRM1
Hydrochloric Acid SCHEMBL5606289 0.97 LMNA (1.00) LMNAALDH1A1KMT2AMEN1OPRM1
SCHEMBL1427926 0.90 LMNA (0.81) LMNAALDH1A1KMT2AMEN1OPRM1
SCHEMBL6663882 0.87 KMT2A (0.73) LMNAALDH1A1KMT2AMEN1OPRM1
SCHEMBL10862008 0.86 KMT2A (0.71) LMNAALDH1A1KMT2AMEN1OPRM1
SCHEMBL20481400 0.86 LMNA (0.71) LMNAALDH1A1KMT2AMEN1OPRM1
SCHEMBL3624300 0.86 KMT2A (0.71) LMNAALDH1A1KMT2AMEN1OPRM1
SCHEMBL6640308 0.86 LMNA (0.71) LMNAALDH1A1KMT2AMEN1OPRM1
SCHEMBL1242029 0.86 ALDH1A1 (0.71) LMNAALDH1A1KMT2AMEN1OPRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6407120-B1 ADMINISTERING PYRIDINYLACETAMIDE OR PHENYLACETAMIDE DERIVATIVE TO TREAT CARDIOVASCULAR, EATING, SEXUAL, BRAIN, NERVOUS SYSTEM, GASTROINTESTINAL, UROGENITAL, PSYCHOLOGICAL, AND RESPIRATORY SYSTEM DISORDERS PFIZER INC. 2002-06-18 US disclosed
EP-1033366-A2 Amide derivatives useful as Neuropeptide Y (NPY) antagonists Pfizer Products Inc. (US) 2000-09-06 EP disclosed